|
1
|
Bornfeldt KE and Tabas I: Insulin
resistance, hyperglycemia and atherosclerosis. Cell Metab.
14:575–585. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hurst RT and Lee RW: Increased incidence
of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms
and management. Ann Intern Med. 139:824–834. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tabas I: Consequences and therapeutic
implications of macrophage apoptosis in atherosclerosis: the
importance of lesion stage and phagocytic efficiency. Arterioscler
Thromb Vasc Biol. 25:2255–2264. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kolodgie FD, Narula J, Burke AP, Haider N,
Farb A, Hui-Liang Y, Smialek J and Virmani R: Localization of
apoptotic macrophages at the site of plaque rupture in sudden
coronary death. Am J Pathol. 157:1259–1268. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liang CP, Han S, Senokuchi T and Tall AR:
The macrophage at the crossroads of insulin resistance and
atherosclerosis. Circ Res. 100:1546–1555. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Burke AP, Kolodgie FD, Zieske A, Fowler
DR, Weber DK, Varghese PJ, Farb A and Virmani R: Morphologic
findings of coronary atherosclerotic plaques in diabetics: a
postmortem study. Arterioscler Thromb Vasc Biol. 24:1266–1271.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Griffiths-Jones S, Grocock RJ, van Dongen
S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets
and gene nomenclature. Nucleic Acids Res. 34:D140–D144. 2006.
View Article : Google Scholar :
|
|
8
|
Zamore PD and Haley B: Ribo-gnome: the big
world of small RNAs. Science. 309:1519–1524. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bentwich I, Avniel A, Karov Y, Aharonov R,
Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, et al:
Identification of hundreds of conserved and nonconserved human
microRNAs. Nat Genet. 37:766–770. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nugent M, Miller N and Kerin MJ: MicroRNAs
in colorectal cancer: function, dysregulation and potential as
novel biomarkers. Eur J Surg Oncol. 7:649–654. 2011. View Article : Google Scholar
|
|
13
|
Hennessy E, Clynes M, Jeppesen PB and
O’Driscoll L: Identification of microRNAs with a role in glucose
stimulated insulin secretion by expression profiling of MIN6 cells.
Biochem Biophys Res Commun. 396:457–462. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Urbich C, Kuehbacher A and Dimmeler S:
Role of microRNAs in vascular diseases, inflammation, and
angiogenesis. Cardiovasc Res. 79:581–588. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Han M, Toli J and Abdellatif M: MicroRNAs
in the cardiovascular system. Curr Opin Cardiol. 26:181–189. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Folini M, Gandellini P, Longoni N, Profumo
V, Callari M, Pennati M, Colecchia M, Supino R, Veneroni S,
Salvioni R, et al: miR-21: an oncomir on strike in prostate cancer.
Mol Cancer. 9:122010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen
H, Dean DB and Zhang C: MicroRNAs are aberrantly expressed in
hypertrophic heart: do they play a role in cardiac hypertrophy? Am
J Pathol. 170:1831–1840. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Roy S, Khanna S, Hussain SR, Biswas S,
Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ and Sen CK: MicroRNA
expression in response to murine myocardial infarction: miR-21
regulates fibroblast metalloprotease-2 via phosphatase and tensin
homologue. Cardiovasc Res. 82:21–29. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheng Y and Zhang C: MicroRNA-21 in
cardiovascular disease. J Cardiovasc Transl Res. 3:251–255. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Weber M, Baker MB, Moore JP and Searles
CD: MiR-21 is induced in endothelial cells by shear stress and
modulates apoptosis and eNOS activity. Biochem Biophys Res Commun.
393:643–648. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen
H, Dean DB and Zhang C: MicroRNA expression signature and
antisense-mediated depletion reveal an essential role of MicroRNA
in vascular neointimal lesion formation. Circ Res. 100:1579–1588.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Raitoharju E, Lyytikäinen LP, Levula M,
Oksala N, Mennander A, Tarkka M, Klopp N, Illig T, Kähönen M,
Karhunen PJ, et al: miR-21, miR-210, miR-34a and miR-146a/b are
up-regulated in human atherosclerotic plaques in the Tampere
vascular study. Atherosclerosis. 219:211–217. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Davis BN, Hilyard AC, Lagna G and Hata A:
SMAD proteins control DROSHA-mediated microRNA maturation. Nature.
454:56–61. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cheng Y, Liu X, Zhang S, Lin Y, Yang J and
Zhang C: MicroRNA-21 protects against the H(2)O(2)-induced injury
on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol.
47:5–14. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
26
|
Selcuklu SD, Donoghue MT and Spillane C:
miR-21 as a key regulator of oncogenic processes. Biochem Soc
Trans. 37:918–925. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lagos-Quintana M, Rauhut R, Yalcin A,
Meyer J, Lendeckel W and Tuschl T: Identification of
tissue-specific microRNAs from mouse. Curr Biol. 12:735–739. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sheedy FJ, Palsson-McDermott E, Hennessy
EJ, Martin C, O’Leary JJ, Ruan Q, Johnson DS, Chen Y and O’Neill
LA: Negative regulation of TLR4 via targeting of the
proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat
Immunol. 11:141–147. 2010. View
Article : Google Scholar
|
|
29
|
Lin Y, Liu X, Cheng Y, Yang J, Huo Y and
Zhang C: Involvement of MicroRNAs in hydrogen peroxide-mediated
gene regulation and cellular injury response in vascular smooth
muscle cells. J Biol Chem. 284:7903–7913. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yin C, Wang X and Kukreja RC: Endogenous
microRNAs induced by heat-shock reduce myocardial infarction
following ischemia-reperfusion in mice. FEBS Lett. 582:4137–4142.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tatsuguchi M, Seok HY, Callis TE, Thomson
JM, Chen JF, Newman M, Rojas M, Hammond SM and Wang DZ: Expression
of microRNAs is dynamically regulated during cardiomyocyte
hypertrophy. J Mol Cell Cardiol. 42:1137–1141. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Carletti MZ, Fiedler SD and Christenson
LK: MicroRNA 21 blocks apoptosis in mouse periovulatory granulosa
cells. Biol Reprod. 83:286–295. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou X, Zhang J, Jia Q, Ren Y, Wang Y, Shi
L, Liu N, Wang G, Pu P, You Y and Kang C: Reduction of miR-21
induces glioma cell apoptosis via activating caspase 9 and 3. Oncol
Rep. 24:195–201. 2010.PubMed/NCBI
|
|
34
|
Dong S, Cheng Y, Yang J, Li J, Liu X, Wang
X, Wang D, Krall TJ, Delphin ES and Zhang C: MicroRNA expression
signature and the role of microRNA-21 in the early phase of acute
myocardial infarction. J Biol Chem. 284:29514–29525. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Thum T, Gross C, Fiedler J, Fischer T,
Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, et
al: MicroRNA-21 contributes to myocardial disease by stimulating
MAP kinase signalling in fibroblasts. Nature. 456:980–984. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liang JL, Xiao DZ, Liu XY, Lin QX, Shan
ZX, Zhu JN, Lin SG and Yu XY: High glucose induces apoptosis in
AC16 human cardiomyocytes via macrophage migration inhibitory
factor and c-Jun N-terminal kinase. Clin Exp Pharmacol Physiol.
37:969–973. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu X, Cheng Y, Yang J, Krall TJ, Huo Y
and Zhang C: An essential role of PDCD4 in vascular smooth muscle
cell apoptosis and proliferation: implications for vascular
disease. Am J Physiol Cell Physiol. 298:C1481–C1488. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yu Y, Kanwar SS, Patel BB, Oh PS, Nautiyal
J, Sarkar FH and Majumdar AP: MicroRNA-21 induces stemness by
downregulating transforming growth factor beta receptor 2 (TGFβR2)
in colon cancer cells. Carcinogenesis. 33:68–76. 2012. View Article : Google Scholar :
|
|
39
|
Gaur AB, Holbeck SL, Colburn NH and Israel
MA: Downregulation of Pdcd4 by mir-21 facilitates glioblastoma
proliferation in vivo. Neuro Oncol. 13:580–590. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cheng Y, Zhu P, Yang J, Liu X, Dong S,
Wang X, Chun B, Zhuang J and Zhang C: Ischaemic
preconditioning-regulated miR-21 protects heart against
ischaemia/reperfusion injury via anti-apoptosis through its target
PDCD4. Cardiovasc Res. 87:431–439. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Allgayer H: Pdcd4, a colon cancer
prognostic that is regulated by a microRNA. Crit Rev Oncol Hematol.
73:185–191. 2010. View Article : Google Scholar
|
